Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. F. San Juan is active.

Publication


Featured researches published by A. F. San Juan.


Leukemia | 2005

Intrahospital supervised exercise training: a complementary tool in the therapeutic armamentarium against childhood leukemia.

Alejandro Lucia; Manuel Ramírez; A. F. San Juan; S. J. Fleck; Javier García-Castro; L Madero

Intrahospital supervised exercise training: a complementary tool in the therapeutic armamentarium against childhood leukemia


British Journal of Sports Medicine | 2006

Serum concentrations of C reactive protein, α1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa

Stuart Semple; Ll Smith; Andrew J. McKune; J Hoyos; Barbara Mokgethwa; A. F. San Juan; Alejandro Lucia; Ahmed A. Wadee

Objectives: To determine serum concentrations of proinflammatory (C reactive protein, complement C3 and C4) and anti-inflammatory (α1 antitrypsin, C1 esterase inhibitor (C1-INH)) acute phase proteins in elite cyclists before and during a three week cycle tour. Methods: Seventeen professional cyclists participating in the Vuelta a Espańa volunteered for the study. Their mean (SD) physical characteristics were: age 28 (1) years; height 1.7 (0.06) m; weight 65 (7) kg; body fat 7.6 (0.8)%; Vo2max 75.3 (2.3) ml/kg/min. Venepuncture was performed on each subject 24 hours before the tour began (T0), on day 11 (the first rest day; T1) and day 21 (the second to last stage of the tour; T2). Samples at T1 and T2 were taken about 17 hours after the previous stage. Analysis of variance was used to determine changes over time. Where significance was found, a Tukey post hoc test was performed. Results: C reactive protein concentrations were consistently within the normal range, although there was a 228%, non-significant increase at T1. C3 concentrations fell within the normal range at all times assessed. C4 concentrations before the race were within the normal range and were significantly increased 10 days (T1) into the race. C1-INH concentrations did not change significantly throughout the race. α1 Antitrypsin concentration before the race was at the lower end of the normal range and was only significantly raised at T2. Conclusions: Although not as pronounced as those reported in marathon/ultramarathon runners, elite cyclists participating in a three week cycle tour experienced increases in selected proinflammatory and anti-inflammatory acute phase proteins, indicating an acute phase/inflammatory response. It is tenable that the increase in α1 antitrypsin and C1-INH (anti-inflammatory mediators) at T2 served to attenuate the acute phase/inflammatory response. The lower than normal resting concentrations of the acute phase proteins supports the notion that chronic aerobic exercise induces an anti-inflammatory state.


British Journal of Sports Medicine | 2006

C34T mutation of the AMPD1 gene in an elite white runner

Alejandro Lucia; Miguel A. Martín; Jonathan Esteve-Lanao; A. F. San Juan; Juan C. Rubio; Jesús Oliván; Joaquín Arenas

The case is reported of an elite, male, white endurance runner (28 years of age), who is one of the best non-African runners in the world despite carrying the C34T mutation in the gene (AMPD1) that encodes the skeletal muscle specific isoform of AMP deaminase, an enzyme that plays an important role in muscle metabolism. The frequency of the mutant allele in sedentary white people is 8–11%. Previous research has shown that this mutation, at least in homozygotes, can impair the exercise capacity of untrained people and their trainability. The maximum oxygen uptake of the study subject was exceptionally high (83.6 ml/kg/min), whereas his ammonia and lactate concentrations at high submaximal running speeds were lower than those of other world class runners who are not carriers of the mutation. The partial metabolic deficiency of the study subject is possibly compensated for by his exceptionally favourable anthropometric characteristics (body mass index 18.2 kg/m2).


International Journal of Sports Medicine | 2006

Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial

F. Herrero; A. F. San Juan; S. J. Fleck; James Balmer; Margarita Pérez; Silvia Cañete; Conrad P. Earnest; Carl Foster; Alejandro Lucia


International Journal of Sports Medicine | 2008

Benefits of intrahospital exercise training after pediatric bone marrow transplantation.

A. F. San Juan; Carolina Chamorro-Viña; Susana Moral; M. Fernández del Valle; L Madero; Manuel Ramírez; Margarita Pérez; Alejandro Lucia


International Journal of Sports Medicine | 2008

Functional Capacity of Children with Leukemia

A. F. San Juan; Carolina Chamorro-Viña; José Luis Maté-Muñoz; M. Fernández del Valle; Cardona C; M. Hernández; L Madero; Margarita Pérez; Manuel Ramírez; Alejandro Lucia


International Journal of Sports Medicine | 2006

Frequency of the VO2max plateau phenomenon in world-class cyclists.

Alejandro Lucia; Manuel Rabadán; Jesús Hoyos; M Hernandez-Capilla; Margarita Pérez; A. F. San Juan; Conrad P. Earnest; José L. Chicharro


International Journal of Sports Medicine | 2007

Effects of inspiratory muscle training on exercise capacity and spontaneous physical activity in elderly subjects: a randomized controlled pilot trial

S. Aznar-Lain; A. L. Webster; Silvia Cañete; A. F. San Juan; L. M. Lopez Mojares; Margarita Pérez; Alejandro Lucia; José L. Chicharro


International Journal of Sports Medicine | 2007

Effects of detraining on the functional capacity of previously trained breast cancer survivors.

F. Herrero; A. F. San Juan; S. J. Fleck; Carl Foster; Alejandro Lucia


International Journal of Sports Medicine | 2006

Changes in mucosal and humoral atopic-related markers and immunoglobulins in elite cyclists participating in the Vuelta a España

Andrew J. McKune; Ll Smith; Stuart Semple; Ahmed A. Wadee; H. Fickl; José G. Villa; Félix Gómez-Gallego; A. F. San Juan; Alejandro Lucia

Collaboration


Dive into the A. F. San Juan's collaboration.

Top Co-Authors

Avatar

Alejandro Lucia

European University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Margarita Pérez

European University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Manuel Ramírez

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

L Madero

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

S. J. Fleck

University of Wisconsin–Parkside

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Félix Gómez-Gallego

European University of Madrid

View shared research outputs
Top Co-Authors

Avatar

José L. Chicharro

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Joaquín Arenas

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Juan C. Rubio

Instituto de Salud Carlos III

View shared research outputs
Researchain Logo
Decentralizing Knowledge